187 related articles for article (PubMed ID: 23170908)
1. Graves' hyperthyroidism and moderate alcohol consumption: evidence for disease prevention.
Carlé A; Bülow Pedersen I; Knudsen N; Perrild H; Ovesen L; Rasmussen LB; Jørgensen T; Laurberg P
Clin Endocrinol (Oxf); 2013 Jul; 79(1):111-9. PubMed ID: 23170908
[TBL] [Abstract][Full Text] [Related]
2. Moderate alcohol consumption may protect against overt autoimmune hypothyroidism: a population-based case-control study.
Carlé A; Pedersen IB; Knudsen N; Perrild H; Ovesen L; Rasmussen LB; Jørgensen T; Laurberg P
Eur J Endocrinol; 2012 Oct; 167(4):483-90. PubMed ID: 22802427
[TBL] [Abstract][Full Text] [Related]
3. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism.
Holm IA; Manson JE; Michels KB; Alexander EK; Willett WC; Utiger RD
Arch Intern Med; 2005 Jul; 165(14):1606-11. PubMed ID: 16043678
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
6. Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients.
Vos XG; Smit N; Endert E; Brosschot JF; Tijssen JG; Wiersinga WM
Eur J Endocrinol; 2009 Feb; 160(2):193-9. PubMed ID: 18974230
[TBL] [Abstract][Full Text] [Related]
7. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism.
Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L
Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733
[TBL] [Abstract][Full Text] [Related]
8. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
9. Thyroid function during pregnancy in women with past Graves' disease.
Luton D; Le Gac I; Noel M; Guibourdenche J; Polak M
BJOG; 2005 Nov; 112(11):1565-7. PubMed ID: 16225580
[TBL] [Abstract][Full Text] [Related]
10. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
11. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score.
Strieder TG; Tijssen JG; Wenzel BE; Endert E; Wiersinga WM
Arch Intern Med; 2008 Aug; 168(15):1657-63. PubMed ID: 18695079
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
[TBL] [Abstract][Full Text] [Related]
13. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
14. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG
Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411
[TBL] [Abstract][Full Text] [Related]
15. Symptomatology of Graves' disease and Plummer's disease in relation to age and thyroid hormone level.
Tak PP; Hermans J; Haak A
Neth J Med; 1993 Jun; 42(5-6):157-62. PubMed ID: 8377872
[TBL] [Abstract][Full Text] [Related]
16. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability.
Chen JL; Chiu HW; Tseng YJ; Chu WC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):611-6. PubMed ID: 16712661
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
[TBL] [Abstract][Full Text] [Related]
18. Smoking and risk of Graves' disease.
Prummel MF; Wiersinga WM
JAMA; 1993 Jan; 269(4):479-82. PubMed ID: 8419666
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
[TBL] [Abstract][Full Text] [Related]
20. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
Clifton-Bligh P; Burke G
J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
